0001209191-21-056425.txt : 20210916
0001209191-21-056425.hdr.sgml : 20210916
20210916170114
ACCESSION NUMBER: 0001209191-21-056425
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210915
FILED AS OF DATE: 20210916
DATE AS OF CHANGE: 20210916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Akinsanya Karen
CENTRAL INDEX KEY: 0001797672
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 211258522
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-15
0
0001490978
Schrodinger, Inc.
SDGR
0001797672
Akinsanya Karen
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR
NEW YORK
NY
10036
0
1
0
0
See Remarks
Common Stock
2021-09-15
4
M
0
1394
4.34
A
1394
D
Common Stock
2021-09-15
4
S
0
1394
61.13
D
0
D
Stock Option (right to buy)
4.34
2021-09-15
4
M
0
1394
0.00
D
2028-11-29
Common Stock
1394
44591
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.
This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
EVP, Chief Biomedical Scientist, Head of Discovery R&D
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
2021-09-16